In a recent study, researchers developed a series of cell lines that may form the basis of a drug screen platform for breast cancer using organoids.
21 Feb 2018

In a recent study, researchers developed a series of cell lines that may form the basis of a drug screen platform for breast cancer using organoids.

 

Applying breast cancer therapies that are appropriate for a specific tumour’s composition, behaviour, and the specific mechanisms which allow it to grow, spread, and survive remains a challenge. Breast cancer models, usually derived from well-studied tumour cell lines or from a patient’s own cells, are often employed as part of a drug screen to establish which drugs a tumour responds to, but the creation of such models can be time-consuming and highly technical. Samples can also…

Continue Reading Article here:

Back to News and Media